Exclusive | KKR Pushes Further Into Healthcare With Deal for Pharma Royalty Business The Wall Street Journal KKR Pushes Further Into Healthcare With Deal for Pharma Royalty Business Yahoo Finance KKR & Co. Acquires Majority Ownership Stake In HCRx Nasdaq KKR buys HealthCare Royalty Partners as firm deepens bet on life sciences Endpoints News KKR Announces Strategic Acquisition of HealthCare Royalty Partners, Expanding the …
Read More »Tag Archives: Pharma
Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027 – Fierce Pharma
Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027 Fierce Pharma Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook CNBC Merck Stock Falls After Layoff Announcement, Gardasil Sales Drop Investor’s Business Daily Merck to Lay Off Workers and Narrows Guidance as Earnings Fall – WSJ The Wall Street Journal Our Q2 2025 financial results Merck.com …
Read More »AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh
The office building of international biopharmaceutical company AstraZeneca. Cfoto | Future Publishing | Getty Images AstraZeneca on Monday said it plans to invest $50 billion in bolstering its U.S. manufacturing and research capabilities by 2030, becoming the latest pharmaceutical firm to ramp up its stateside spending in the wake of U.S. trade tariffs. The Anglo-Swedish biotech company, which is headquartered …
Read More »Bristol Myers braves failed Reblozyl phase 3, plans FDA talks for potential anemia expansion – Fierce Pharma
Bristol Myers braves failed Reblozyl phase 3, plans FDA talks for potential anemia expansion Fierce Pharma BMS’ Anemia Drug Reblozyl Flunks Phase III Myelofibrosis Trial BioSpace Bristol Myers Squibb’s Reblozyl fails Phase 3 in anemia; Sanofi, Blueprint deal closes Endpoints News Retail Chatter On BMY Doubles In 24 Hours With Drug Failing To Meet Primary Goal: Here’s What Investors Are Thinking Stocktwits Luspatercept Plus …
Read More »